Hepatic Iron Overload Induces Hepatocellular Carcinoma in Transgenic Mice Expressing the Hepatitis C Virus Polyprotein

Gastroenterology

Volumn 130, Issue 7, 2006, Pages 2087-2098

  Furutani, Takakazu ^a   Hino, Keisuke ^a   Okuda, Michiari ^a   Gondo, Toshikazu ^b   Nishina, Sohji ^a   Kitase, Akira ^a   Korenaga, Masaaki ^a   Xiao, Shu Yuan ^c,d   Weinman, Steven A ^c,d   Lemon, Stanley M ^c,d   Sakaida, Isao ^a   Okita, Kiwamu ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; FATTY ACID; IRON; POLYPROTEIN; TRIACYLGLYCEROL; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; FATTY ACID OXIDATION; FATTY LIVER; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IRON INTAKE; IRON OVERLOAD; LIPID PEROXIDATION; LIVER CELL; LIVER CELL CARCINOMA; LIVER LEVEL; MALE; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; VIRUS CARCINOGENESIS;

EID: 33744512454     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.02.060     Document Type: Article

References (43)

1. El-Serag H.B., and Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 240 (1999) 745-750
2. Kiyosawa K., Tanaka E., and Sodeyama T. Hepatitis C virus and hepatocellular carcinoma. In: Reesink H.W. (Ed). Hepatitis C virus (1998), Karger, Basel 161-180
3. Barbaro G., Di Lorenzo G., Asti A., Ribersani M., Belloni G., Grisorio B., Filice G., and Barbarini G. Hepatocellular mitochondrial alterations in patients with chronic hepatitis C. ultrastructural and biochemical findings. Am J Gastroenterol 94 (1999) 2198-2205
4. Valgimigli M., Valgimigli L., Trere D., Gaiani S., Pedulli G.F., Gramantieri L., and Bolondi L. Oxidative stress EPR measurement in human liver by radical-probe technique. Correlation with etiology, histology and cell proliferation. Free Radic Res 36 (2002) 939-948
5. Okuda M., Li K., Beard M.R., Showalter L.A., Scholle F., Lemon S.M., and Weinman S.A. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122 (2002) 366-375
6. Kageyama F., Kobayashi Y., Kawasaki T., Toyokuni S., Uchida K., and Nakamura H. Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C. Am J Gastroenterol 95 (2000) 1041-1050
7. Farinati F., Cardin R., De Maria N., Della Libera G., Marafin C., Lecis E., Burra P., Floreani A., Cecchetto A., and Naccarato R. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 22 (1995) 449-456
8. Di Bisceglie A.M., Axiotis C.A., Hoofnagle J.H., and Bacon B.R. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 102 (1992) 2108-2113
9. Haque S., Chandra B., Gerber M.A., and Lok A.S. Iron overload in patients with chronic hepatitis C. a clinicopathologic study. Hum Pathol 27 (1996) 1277-1281
10. Fenton H.J.H. Oxidation of tartaric acid in presence of iron. J Chem Soc 65 (1894) 899-910
11. Kowdley K.V. Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology 127 (2004) S79-S86
12. Liang T.J., and Heller T. Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gastroenterology 127 (2004) S62-S67
13. Lerat H., Honda M., Beard M.R., Loesch K., Sun J., Yang Y., Okuda M., Gosert R., Xiao S.Y., Weinman S.A., and Lemon S.M. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 122 (2002) 352-365
14. Beard M.R., Abell G., Honda M., Carroll A., Gartland M., Clarke B., Suzuki K., Lanford R., Sangar D.V., and Lemon S.M. An infectious molecular clone of a Japanese genotype 1b hepatitis C virus. Hepatology 30 (1999) 316-324
15. Smith M.A., Harris P.L., Sayre L.M., and Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci U S A 94 (1997) 9866-9868
16. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37 (1959) 911-917
17. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
18. Geneve J., Hayat-Bonan B., Labbe G., Degott C., Letteron P., Freneaux E., Dinh T.L., Larrey D., and Pessayre D. Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug. J Pharmacol Exp Ther 242 (1987) 1133-1137
19. Hofer H., Osterreicher C., Jessner W., Penz M., Steindl-Munda P., Wrba F., and Ferenci P. Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C. J Hepatol 40 (2004) 1018-1022
20. Rulyak S.J., Eng S.C., Patel K., McHutchison J.G., Gordon S.C., and Kowdley K.V. Relationships between hepatic iron content and virologic response in chronic hepatitis C patients treated with interferon and ribavirin. Am J Gastroenterol 100 (2005) 332-337
21. Nemeth E., Rivera S., Gabayan V., Keller C., Taudorf S., Pedersen B.K., and Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113 (2004) 1271-1276
22. Lee P., Peng H., Gelbart T., and Beutler E. The IL-6- and lipopolysaccharide-induced transcription of hepcidin in HFE-, transferrin receptor 2-, and beta 2-microglobulin-deficient hepatocytes. Proc Natl Acad Sci U S A 101 (2004) 9263-9265
23. Rao M.S., and Reddy J.K. Peroxisomal beta-oxidation and steatohepatitis. Semin Liver Dis 21 (2001) 43-55
24. Chenoufi N., Loreal O., Drenou B., Cariou S., Hubert N., Leroyer P., Brissot P., and Lescoat G. Iron may induce both DNA synthesis and repair in rat hepatocytes stimulated by EGF/pyruvate. J Hepatol 26 (1997) 650-658
25. Hann H.W., Stahlhut M.W., and Hann C.L. Effect of iron and desferoxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines. Hepatology 11 (1990) 566-569
26. Deugnier Y., and Turlin B. Iron and hepatocellular carcinoma. J Gastroenterol Hepatol 16 (2001) 491-494
27. Goodman Z.D., and Ishak K.G. Histopathology of hepatitis C virus infection. Semin Liver Dis 15 (1995) 70-81
28. Pigeon C., Turlin B., Iancu T.C., Leroyer P., Le Lan J., Deugnier Y., Brissot P., and Loreal O. Carbonyl-iron supplementation induces hepatocyte nuclear changes in BALB/CJ male mice. J Hepatol 30 (1999) 926-934
29. Park C.H., Bacon B.R., Brittenham G.M., and Tavill A.S. Pathology of dietary carbonyl iron overload in rats. Lab Invest 57 (1987) 555-563
30. Krause A., Neitz S., Magert H.J., Schulz A., Forssmann W.G., Schulz-Knappe P., and Adermann K. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480 (2000) 147-150
31. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., Ganz T., and Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 (2004) 2090-2093
32. Nishina S., Hino K., Hidaka I., Furutani T., Yamaguchi Y., Korenaga M., Okuda M., Lemon S.M., and Okita K. Iron overload develops in the absence of hepatic inflammation in transgenic mice expressing the hepatitis C virus polyprotein. (abstr). Hepatology 42 (2005) 916A
33. Carthew P., Edwards R.E., Smith A.G., Dorman B., and Francis J.E. Rapid induction of hepatic fibrosis in the gerbil after the parenteral administration of iron-dextran complex. Hepatology 13 (1991) 534-539
34. Carthew P., Dorman B.M., Edwards R.E., Francis J.E., and Smith A.G. A unique rodent model for both the cardiotoxic and hepatotoxic effects of prolonged iron overload. Lab Invest 69 (1993) 217-222
35. Bove K.E., McAdams A.J., Partin J.C., Partin J.S., Hug G., and Schubert W.K. The hepatic lesion in Reye's syndrome. Gastroenterology 69 (1975) 685-697
36. Burroughs A.K., Seong N.H., Dojcinov D.M., Scheuer P.J., and Sherlock S.V. Idiopathic acute fatty liver of pregnancy in 12 patients. Q J Med 51 (1982) 481-497
37. Lemasters J.J., and Nieminen A.L. Mitochondrial oxygen radical formation during reductive and oxidative stress to intact hepatocytes. Biosci Rep 17 (1997) 281-291
38. Hughes D.E., Stolz D.B., Yu S., Tan Y., Reddy J.K., Watkins S.C., Diehl A.M., and Costa R.H. Elevated hepatocyte levels of the Forkhead box A2 (HNF-3beta) transcription factor cause postnatal steatosis and mitochondrial damage. Hepatology 37 (2003) 1414-1424
39. Perlemuter G., Sabile A., Letteron P., Vona G., Topilco A., Chretien Y., Koike K., Pessayre D., Chapman J., Barba G., and Brechot C. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion. a model of viral-related steatosis. FASEB J 16 (2002) 185-194
40. Tanguy S., de Leiris J., Besse S., and Boucher F. Ageing exacerbates the cardiotoxicity of hydrogen peroxide through the Fenton reaction in rats. Mech Ageing Dev 124 (2003) 229-235
41. Moriya K., Fujie H., Shintani Y., Yotsuyanagi H., Tsutsumi T., Ishibashi K., Matsuura Y., Kimura S., Miyamura T., and Koike K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4 (1998) 1065-1067
42. Moriya K., Nakagawa K., Santa T., Shintani Y., Fujie H., Miyoshi H., Tsutsumi T., Miyazawa T., Ishibashi K., Horie T., Imai K., Todoroki T., Kimura S., and Koike K. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 61 (2001) 4365-4370
43. Kato J., Kobune M., Nakamura T., Kuroiwa G., Takada K., Takimoto R., Sato Y., Fujikawa K., Takahashi M., Takayama T., Ikeda T., and Niitsu Y. Normalization of elevated hepatic 8-hydroxy-2′-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet. Cancer Res 61 (2001) 8697-8702